Aster DM Healthcare declined 3.70% to Rs 152.35 after the company's consolidated net profit dropped 20.2% to Rs 116.72 crore on 4.8% rise in net sales to Rs 2,390.88 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax declined 16.6% to Rs 121.97 crore in Q4 FY21 as against Rs 146.26 crore in Q4 FY20. The Q4 earnings were announced after trading hours yesterday, 22 June 2021.
EBITDA (excluding other income and fair value of put option) fell 17% to Rs 336 crore in Q4 FY21 as against Rs 404 crore in Q4 FY20.
Among business segments, revenue from Hospitals jumped 11.53% to Rs 1,313.70 crore in Q4 March 2021 from Rs 1,177.79 crore in Q4 March 2020. Revenue from Clinics climbed 13.07% to Rs 586.45 crore in Q4 March 2021 as against Rs 518.62 crore in Q4 March 2020. Revenue from Retail Pharmacies (including opticals) declined 15.76% to Rs 488.26 crore in Q4 March 2021 as against Rs 579.65 crore in Q4 March 2020.
During the financial year, Aster DM Healthcare's consolidated net profit lost 43.48% to Rs 177.83 crore on 0.50% decrease in revenue from operations to Rs 8,608.43 crore in FY 2021 over FY 2020.
Aster DM Healthcare operates in various segments of the healthcare industry, which include hospitals, clinics and retail pharmacies, and provides healthcare services to patients across economic segments in various gulf corporation council (GCC) states through its various brands, such as Aster, Medcare and Access.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
